Key facts
- Notable investors include Khanu Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for REVIER Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for REVIER Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About REVIER Therapeutics
Developer of therapeutic devices designed for the management of cardiac conditions in Germany. The company is currently operating in Stealth mode
- Sector
- Healthcare
- HQ
- Heidelberg, Germany
- Founded
- 2023
- Ownership
- Privately Held (backing)
REVIER Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in REVIER Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on REVIER Therapeutics in its N-PORT filings yet. We sweep new filings monthly.